This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
31 Oct 2025

Naloxone- BFS (Naloxone 0.4mg/ml - Solution for injection)

Naloxone- BFS (Naloxone 0.4mg/ml - Solution for injection)

Composition: Naloxone 0.4mg/ml.


Dosage Form: Solution for injection.


Indication: Complete or partial reversal of CNS depressive effects, especially respiratory depression, caused by natural or synthetic opioids and partial agonist/antagonist opioids.


Diagnosis of suspected acute opioid overdose or intoxication.


Naloxone has been used off-label for the treatment of neuraxial opioid-induced pruritus

Dosage Adminstration: The medicinal product can be injected intravenously (i.v.), intramuscularly (i.m.) or can be given via intravenous infusion.


The i.m. administration of naloxone hydrochloride should only be used in cases where an i.v. administration is not possible.


The most rapid effect is obtained by means of i.v. administration, which is why this method of administration is recommended in acute cases.

Mentioned Companies
Ha Noi CPC1 Pharmaceutical Joint Stock Company
View company profile